Complementing Observational Signals with Literature-Derived Distributed Representations for Post-Marketing Drug Surveillance

被引：0
|
作者：
Justin Mower
Trevor Cohen
Devika Subramanian
机构：
[1] Rice University,Department of Computer Science
[2] University of Washington,undefined
[3] Biomedical Informatics and Medical Education,undefined
来源：
Drug Safety | 2020年 / 43卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：67 / 77
页数：10
相关论文
共 50 条
  • [31] Proportional reporting ratios as a method to develop signals for post-marketing surveillance of leflunomide.
    Cannon, GW
    Strand, V
    Scarazzini, L
    Holden, WL
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S331 - S331
  • [32] Post-marketing safety surveillance of sacituzumab govitecan: an observational, pharmacovigilance study leveraging FAERS database
    Liu, Wensheng
    Du, Qiong
    Guo, Zihan
    Ye, Xuan
    Liu, Jiyong
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [33] Evaluation of Electronic Healthcare Databases for Post-Marketing Drug Safety Surveillance and Pharmacoepidemiology in China
    Yu Yang
    Xiaofeng Zhou
    Shuangqing Gao
    Hongbo Lin
    Yanming Xie
    Yuji Feng
    Kui Huang
    Siyan Zhan
    Drug Safety, 2018, 41 : 125 - 137
  • [34] The European Post-marketing Observational Sertindole Study: an investigation of the safety of antipsychotic drug treatment
    Kasper, Siegfried
    Moeller, Hans-Juergen
    Hale, Anthony
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2010, 260 (01) : 59 - 68
  • [35] LETTER TO THE MEDICAL-PROFESSION INITIATION OF POST-MARKETING DRUG SURVEILLANCE PROGRAM IN KUWAIT
    MOUSSA, MAA
    JOURNAL OF THE KUWAIT MEDICAL ASSOCIATION, 1982, 16 (01): : 61 - 62
  • [36] IS POST-MARKETING DRUG SURVEILLANCE POSSIBLE IN THE FAMILY-PRACTICE SETTING - A COLLABORATIVE STUDY
    FACKLAM, DP
    BAKER, MI
    GARDNER, JS
    HERBERT, C
    GRAVAGUBINS, I
    CANADIAN FAMILY PHYSICIAN, 1988, 34 : 819 - 822
  • [37] POST-MARKETING SURVEILLANCE OF ADVERSE DRUG-REACTIONS - AN EXPERIENCE WITH GENERAL-PRACTITIONERS
    HARAMBURU, F
    PERE, JC
    BEGAUD, B
    ALBIN, H
    THERAPIE, 1985, 40 (05): : 321 - 324
  • [38] Exenatide drug label to include information on post-marketing surveillance of altered kidney function
    不详
    FORMULARY, 2010, 45 (01) : 28 - 28
  • [39] The European Post-marketing Observational Sertindole Study: an investigation of the safety of antipsychotic drug treatment
    Siegfried Kasper
    Hans-Jürgen Möller
    Anthony Hale
    European Archives of Psychiatry and Clinical Neuroscience, 2010, 260 : 59 - 68
  • [40] Evaluation of Electronic Healthcare Databases for Post-Marketing Drug Safety Surveillance and Pharmacoepidemiology in China
    Yang, Yu
    Zhou, Xiaofeng
    Gao, Shuangqing
    Lin, Hongbo
    Xie, Yanming
    Feng, Yuji
    Huang, Kui
    Zhan, Siyan
    DRUG SAFETY, 2018, 41 (01) : 125 - 137
12345